Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.740
-0.240 (-8.05%)
At close: Oct 10, 2025, 4:00 PM EDT
2.750
+0.010 (0.36%)
After-hours: Oct 10, 2025, 7:48 PM EDT

Eledon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
164246443163233
Upgrade
Market Cap Growth
66.17%465.19%38.75%-50.21%-72.98%3004.20%
Upgrade
Enterprise Value
57.31162.4948.18-24.61-21.34119.28
Upgrade
Last Close Price
2.744.121.802.284.4115.40
Upgrade
PE Ratio
12.92-6.24-0.48-0.37-1.89-0.98
Upgrade
PB Ratio
1.553.94-0.900.370.381.22
Upgrade
P/TBV Ratio
3.763.20-0.910.390.400.12
Upgrade
P/FCF Ratio
--5.21-1.10-1.11-2.18-15.35
Upgrade
P/OCF Ratio
--5.21-1.10-1.11-2.18-15.35
Upgrade
EV/EBITDA Ratio
--2.30-1.120.280.58-6.46
Upgrade
EV/EBIT Ratio
--2.30-1.120.280.58-6.46
Upgrade
EV/FCF Ratio
--3.44-1.220.870.74-7.84
Upgrade
Debt / Equity Ratio
0.000.0100.000.000
Upgrade
Debt / EBITDA Ratio
-0.01-0.01-0.01-0.01-0.02-0.01
Upgrade
Debt / FCF Ratio
-0.01-0.02-0.01-0.03-0.03-0.01
Upgrade
Quick Ratio
7.8412.1113.128.7119.2845.99
Upgrade
Current Ratio
8.1212.4214.419.1920.0746.57
Upgrade
Return on Equity (ROE)
13.45%-56.36%-255.03%-70.89%-22.12%-23.61%
Upgrade
Return on Assets (ROA)
-54.54%-52.33%-47.29%-67.16%-21.33%-18.05%
Upgrade
Return on Capital (ROIC)
-259.19%-203.76%-126.30%-152.19%-47.75%-45.36%
Upgrade
Return on Capital Employed (ROCE)
-59.19%-56.24%-50.15%-70.05%-20.43%-18.08%
Upgrade
Earnings Yield
8.92%-16.02%-207.78%-270.18%-52.83%-102.08%
Upgrade
FCF Yield
-39.33%-19.19%-90.69%-90.49%-45.83%-6.52%
Upgrade
Buyback Yield / Dilution
0.00%-54.20%-75.76%0.00%-0.00%-6.15%
Upgrade
Total Shareholder Return
--54.20%-75.76%0.00%-0.00%-6.15%
Upgrade
Updated Aug 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q